Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial-Reference-Cited by-同舟云学术

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Published:2023-03 Issue:3 Volume:34 Page:251-261
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chan A.T.C.,Lee V.H.F.,Hong R.-L.,Ahn M.-J.,Chong W.Q.,Kim S.-B.,Ho G.F.,Caguioa P.B.,Ngamphaiboon N.,Ho C.,Aziz M.A.S.A.,Ng Q.S.,Yen C.-J.,Soparattanapaisarn N.,Ngan R.K.-C.,Kho S.K.,Tiambeng M.L.A.,Yun T.,Sriuranpong V.,Algazi A.P.,Cheng A.,Massarelli E.,Swaby R.F.,Saraf S.,Yuan J.,Siu L.L.

Funder

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference24 articles.

1. Nasopharyngeal carcinoma: an evolving paradigm;Wong;Nat Rev Clin Oncol,2021

2. Nasopharyngeal carcinoma;Chen;Lancet,2019

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

4. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up;Bossi;Ann Oncol,2021

5. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives;Lang;Cancer Manag Res,2019

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer;Chemotherapy;2024-07-17

2. A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies;Cancer Treatment Reviews;2024-07

3. Immune checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis of random controlled trials;European Archives of Oto-Rhino-Laryngology;2024-06-24

4. Case report: Immunotherapy-based combination therapy achieving complete remission and prolonged survival in nasopharyngeal carcinoma with extensive bone marrow metastasis;Frontiers in Immunology;2024-06-24

5. PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trials;Frontiers in Oncology;2024-06-03